Improving survival of stage II‐III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy-Reference-Cited by-同舟云学术

Improving survival of stage II‐III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy

Published:2020-08-03 Issue:18 Volume:9 Page:6617-6628
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Li Yang¹^ORCID,Zhu Zhikai²³,Ma Fuhai¹,Xue Liyan⁴,Tian Yantao¹

Affiliation:

1. Department of Pancreatic and Gastric Surgery National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences & Peking Union Medical College Beijing China

2. School of Public Health Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China

3. Department of Oncology Georgetown University School of Medicine Washington DC USA

4. Department of Pathology National Cancer Center/Cancer HospitalChinese Academy of Medical Sciences & Peking Union Medical College Beijing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3342

Reference32 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Gastric cancer: classification, histology and application of molecular pathology;Hu B;J Gastrointest Oncol,2012

3. Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma

4. 2010 JARC Lyon GCF Lauwers D Graham M Curado FCF Bosman R Hruban N Theise Gastric carcinoma. WHO classification of tumors of the digestive system 48 58

5. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973–2000 Increase in the Signet Ring Cell Type;Henson DE;Arch Pathol Lab Med,2004

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analyzing risk factors for second malignancies in early gastric carcinoma from the SEER database;Scientific Reports;2024-08-01

2. Is neoadjuvant chemotherapy followed by surgery the appropriate treatment for esophagogastric signet ring cell carcinomas? A systematic review and meta-analysis;Frontiers in Surgery;2024-05-06

3. Prognostic Survival Significance of Signet Ring Cell (SRC) Gastric Cancer: Retrospective Analysis from a Single Western Center;Journal of Personalized Medicine;2023-07-19

4. Individualised adjuvant immunotherapy with neoantigen‐reactive T cells for gastric signet‐ring cell carcinoma;Clinical & Translational Immunology;2023-01

5. Clinical Efficacy of Acupuncture on Neoadjuvant Chemotherapy with Capecitabine plus Paclitaxel and Radiotherapy in Progressive Gastric Cancer;Journal of Oncology;2022-07-12